Silex成立于1996年，源自Sonic Healthcare，开发激光同位素分离技术。

这家市值11亿澳元的公司由JPMorgan和Canaccord Genuity担任联合主承销商，正在以每股3.90澳元的价格向投资者募集资金，这相当于最后成交价的15.8%折扣。

基金经理被告知，Silex将利用这笔资金将其全球激光浓缩（GLE）技术商业化，特别是在美国。GLE是Silex与全球铀及核燃料供应商Cameco Corporation的合资项目，用于铀浓缩。

Silex还计划通过配股计划再筹集1500万澳元。

此外，Silex还宣布被邀请竞标来自美国能源部的9亿美元（约合13.8亿澳元）资金，投标截止日期为8月25日。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.